Skip to main content
SpringerLink
Log in

Genetic Polymorphisms of P-glycoprotein: Echoes of Silence

  • Chapter
  • First Online:
ABC Transporters - 40 Years on

Abstract

ABCB1 is a polymorphic gene that encodes a full ABC transporter with drug-binding pockets and two nucleotide-binding ATPase domains. It was one of the first members of the ABC transporter superfamily to be identified in humans. Since the discovery of this gene nearly 40 years ago, many mutations and polymorphisms in the coding region have been shown to have functional significance. Common genetic variations in the form of single nucleotide polymorphisms (SNPs) of ABCB1 have been shown to have a role in disease susceptibility and drug response. In this chapter, we summarize our current understanding of common ABCB1 SNPs and their impact on protein folding, drug transport function, disease risk factors, and drug pharmacokinetics. Unfortunately, clinical studies on the association of drug effects and ABCB1 polymorphisms are often inconclusive. In the past few years, meta-analyses of ABCB1 polymorphism studies have been carried out in attempts to draw more consistent conclusions. Among ABCB1 SNPs, the synonymous C3435T polymorphic site is perhaps one of the best-known silent mutations in the field of pharmacogenomics. Our current understanding of the mechanism of the effect of this “silent” SNP is discussed here. Overall, research efforts in the past 15 years have laid important groundwork concerning the effect of ABCB1 variants that should lead to advances in precision medicine in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akiyama S, Fojo A, Hanover JA, Pastan I, Gottesman MM (1985) Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 11(2):117–126

    Article  CAS  PubMed  Google Scholar 

  • Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, Chang G (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323(5922):1718–1722

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ambudkar SV, Kim IW, Xia D, Sauna ZE (2006a) The A-loop, a novel conserved aromatic acid subdomain upstream of the Walker A motif in ABC transporters, is critical for ATP binding. FEBS Lett 580(4):1049–1055

    Article  CAS  PubMed  Google Scholar 

  • Ambudkar SV, Kim IW, Sauna ZE (2006b) The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). Eur J Pharm Sci 27(5):392–400

    Article  CAS  PubMed  Google Scholar 

  • Ameyaw MM, Regateiro F, Li T, Liu X, Tariq M, Mobarek A, Thornton N, Folayan GO, Githang’a J, Indalo A, Ofori-Adjei D, Price-Evans DA, McLeod HL (2001) MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 11(3):217–221

    Article  CAS  PubMed  Google Scholar 

  • Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181(96):223–230

    Article  CAS  PubMed  Google Scholar 

  • Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B, Beaune P, Legendre C, Thervet E (2003) Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol 14(7):1889–1896

    Article  CAS  PubMed  Google Scholar 

  • Bailey SF, Hinz A, Kassen R (2014) Adaptive synonymous mutations in an experimentally evolved Pseudomonas fluorescens population. Nat Commun 5:4076

    Article  CAS  PubMed  Google Scholar 

  • Bartoszewski RA, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J, Collawn JF, Bebok Z (2010) A synonymous single nucleotide polymorphism in DeltaF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein. J Biol Chem 285(37):28741–28748

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hebuterne X, Harel-Bellan A, Mograbi B, Darfeuille-Michaud A, Hofman P (2011) A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease. Nat Genet 43(3):242–245

    Article  CAS  PubMed  Google Scholar 

  • Cascorbi I, Haenisch S (2010) Pharmacogenetics of ATP-binding cassette transporters and clinical implications. Methods Mol Biol 596:95–121

    Article  CAS  PubMed  Google Scholar 

  • Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I (2001) Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 69(3):169–174

    Article  CAS  PubMed  Google Scholar 

  • Chen YN, Mickley LA, Schwartz AM, Acton EM, Hwang JL, Fojo AT (1990) Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J Biol Chem 265(17):10073–10080

    CAS  PubMed  Google Scholar 

  • Cheng JW, Zhang LJ, Hou YQ, Zhao Q, Zhang XJ, Chen XF, Bai Y (2014) Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: a systematic review and meta-analysis. Epilepsy Behav 36:173–179

    Article  PubMed  Google Scholar 

  • Choi KH, Chen CJ, Kriegler M, Roninson IB (1988) An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell 53(4):519–529

    Article  CAS  PubMed  Google Scholar 

  • Chowbay B, Cumaraswamy S, Cheung YB, Zhou Q, Lee EJ (2003) Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. Pharmacogenetics 13(2):89–95

    Article  CAS  PubMed  Google Scholar 

  • Chufan EE, Kapoor K, Sim HM, Singh S, Talele TT, Durell SR, Ambudkar SV (2013) Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1). PLoS ONE 8(12):e82463

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chufan EE, Sim HM, Ambudkar SV (2015) Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies. Adv Cancer Res 125:71–96

    Article  PubMed  Google Scholar 

  • Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA (2006) ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clin Pharmacol Ther 80(6):682–690

    Article  CAS  PubMed  Google Scholar 

  • Dawson RJ, Locher KP (2006) Structure of a bacterial multidrug ABC transporter. Nature 443(7108):180–185

    Article  CAS  PubMed  Google Scholar 

  • Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11(7):1156–1166

    Article  CAS  PubMed  Google Scholar 

  • Decleves X, Chevillard S, Charpentier C, Vielh P, Laplanche JL (2000) A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein. Hum Mutat 15(5):486

    Article  CAS  PubMed  Google Scholar 

  • Dennis BB, Bawor M, Thabane L, Sohani Z, Samaan Z (2014) Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis. PLoS ONE 9(1):e86114

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Di Paolo A, Polillo M, Capecchi M, Cervetti G, Barate C, Angelini S, Guerrini F, Fontanelli G, Arici R, Ciabatti E, Grassi S, Bocci G, Hrelia P, Danesi R, Petrini M, Galimberti S (2014) The c.480C > G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia. Pharmacogenomics J 14(4):328–335

    Article  PubMed  CAS  Google Scholar 

  • Dittmar KA, Goodenbour JM, Pan T (2006) Tissue-specific differences in human transfer RNA expression. PLoS Genet 2(12):e221

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Doxani C, Voulgarelis M, Zintzaras E (2013) MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis. Biomarkers 18(5):425–435

    Article  CAS  PubMed  Google Scholar 

  • Dudarewicz M, Baranska M, Rychlik-Sych M, Trzcinski R, Dziki A, Skretkowicz J (2012) C3435T polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish population. Pharmacol Rep 64(2):343–350

    Article  CAS  PubMed  Google Scholar 

  • Ebid AH, Ahmed MM, Mohammed SA (2007) Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. Ther Drug Monit 29(3):305–312

    Article  PubMed  Google Scholar 

  • Engen RM, Marsh S, Van Booven DJ, McLeod HL (2006) Ethnic differences in pharmacogenetically relevant genes. Curr Drug Targets 7(12):1641–1648

    Article  CAS  PubMed  Google Scholar 

  • Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84(1):265–269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fromm MF (2004) Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 25(8):423–429

    Article  CAS  PubMed  Google Scholar 

  • Fung KL, Gottesman MM (2009) A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta 1794(5):860–871

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fung KL, Pan J, Ohnuma S, Lund PE, Pixley JN, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM (2014) MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer. Cancer Res 74(2):598–608

    Article  CAS  PubMed  Google Scholar 

  • Furuno T, Landi MT, Ceroni M, Caporaso N, Bernucci I, Nappi G, Martignoni E, Schaeffeler E, Eichelbaum M, Schwab M, Zanger UM (2002) Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson’s disease. Pharmacogenetics 12(7):529–534

    Article  CAS  PubMed  Google Scholar 

  • Gardner ER, Burger H, van Schaik RH, van Oosterom AT, de Bruijn EA, Guetens G, Prenen H, de Jong FA, Baker SD, Bates SE, Figg WD, Verweij J, Sparreboom A, Nooter K (2006) Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib. Clin Pharmacol Ther 80(2):192–201

    Article  CAS  PubMed  Google Scholar 

  • Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, Lin JC, Davis S, Simhadri VL, Jha S, Katagiri N, Gotea V, Teer JK, Wei X, Morken MA, Bhanot UK, Chen G, Elnitski LL, Davies MA, Gershenwald JE, Carter H, Karchin R, Robinson W, Robinson S, Rosenberg SA, Collins FS, Parmigiani G, Komar AA, Kimchi-Sarfaty C, Hayward NK, Margulies EH, Samuels Y, Becker J, Benjamin B, Blakesley R, Bouffard G, Brooks S, Coleman H, Dekhtyar M, Gregory M, Guan X, Gupta J, Han J, Hargrove A, Ho SL, Johnson T, Legaspi R, Lovett S, Maduro Q, Masiello C, Maskeri B, McDowell J, Montemayor C, Mullikin J, Park M, Riebow N, Schandler K, Schmidt B, Sison C, Stantripop M, Thomas J, Thomas P, Vemulapalli M, Young A (2013) Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci USA 110(33):13481–13486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Germann UA, Chambers TC, Ambudkar SV, Licht T, Cardarelli CO, Pastan I, Gottesman MM (1996) Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem 271(3):1708–1716

    Article  CAS  PubMed  Google Scholar 

  • Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427

    Article  CAS  PubMed  Google Scholar 

  • Gottesman MM, Pastan I, Ambudkar SV (1996) P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 6(5):610–617

    Article  CAS  PubMed  Google Scholar 

  • Gow JM, Hodges LM, Chinn LW, Kroetz DL (2008) Substrate-dependent effects of human ABCB1 coding polymorphisms. J Pharmacol Exp Ther 325(2):435–442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Green H, Soderkvist P, Rosenberg P, Horvath G, Peterson C (2006) mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy. Clin Cancer Res 12(3 Pt 1):854–859

    Article  CAS  PubMed  Google Scholar 

  • Gribar JJ, Ramachandra M, Hrycyna CA, Dey S, Ambudkar SV (2000) Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system. J Membr Biol 173(3):203–214

    Article  CAS  PubMed  Google Scholar 

  • Gurney H, Wong M, Balleine RL, Rivory LP, McLachlan AJ, Hoskins JM, Wilcken N, Clarke CL, Mann GJ, Collins M, Delforce SE, Lynch K, Schran H (2007) Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype. Clin Pharmacol Ther 82(1):33–40

    Article  CAS  PubMed  Google Scholar 

  • Hafkemeyer P, Dey S, Ambudkar SV, Hrycyna CA, Pastan I, Gottesman MM (1998) Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein. Biochemistry 37(46):16400–16409

    Article  CAS  PubMed  Google Scholar 

  • Hamdy SI, Hiratsuka M, Narahara K, Endo N, El-Enany M, Moursi N, Ahmed MS, Mizugaki M (2003) Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol 55(6):560–569

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • He T, Mo A, Zhang K, Liu L (2013) ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies. Colorectal Dis 15(1):12–18

    Article  CAS  PubMed  Google Scholar 

  • Higgins CF (1992) ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8:67–113

    Article  CAS  PubMed  Google Scholar 

  • Hirt D, Mentre F, Tran A, Rey E, Auleley S, Salmon D, Duval X, Treluyer JM (2008) Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients. Br J Clin Pharmacol 65(4):548–557

    Article  CAS  PubMed  Google Scholar 

  • Ho GT, Soranzo N, Nimmo ER, Tenesa A, Goldstein DB, Satsangi J (2006) ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet 15(5):797–805

    Article  CAS  PubMed  Google Scholar 

  • Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97(7):3473–3478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Horinouchi M, Sakaeda T, Nakamura T, Morita Y, Tamura T, Aoyama N, Kasuga M, Okumura K (2002) Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin. Pharm Res 19(10):1581–1585

    Article  CAS  PubMed  Google Scholar 

  • Horio M, Chin KV, Currier SJ, Goldenberg S, Williams C, Pastan I, Gottesman MM, Handler J (1989) Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia. J Biol Chem 264(25):14880–14884

    CAS  PubMed  Google Scholar 

  • Horwitz SB, Cohen D, Rao S, Ringel I, Shen HJ, Yang CP (1993) Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr 15:55–61

    Google Scholar 

  • Hrycyna CA, Ramachandra M, Ambudkar SV, Ko YH, Pedersen PL, Pastan I, Gottesman MM (1998) Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites. J Biol Chem 273(27):16631–16634

    Article  CAS  PubMed  Google Scholar 

  • Hubacek JA (2014) Drug metabolising enzyme polymorphisms in Middle- and Eastern-European Slavic populations. Drug Metabol Drug Interact 29(1):29–36

    Article  CAS  PubMed  Google Scholar 

  • Ieiri I (2012) Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2). Drug Metab Pharmacokinet 27(1):85–105

    Article  CAS  PubMed  Google Scholar 

  • Ikemura T (1985) Codon usage and tRNA content in unicellular and multicellular organisms. MolBiolEvol 2(1):13–34

    CAS  Google Scholar 

  • Jeong H, Herskowitz I, Kroetz DL, Rine J (2007) Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay. PLoS Genet 3(3):e39

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Johnatty SE, Beesley J, Paul J, Fereday S, Spurdle AB, Webb PM, Byth K, Marsh S, McLeod H, Harnett PR, Brown R, DeFazio A, Chenevix-Trench G (2008) ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Clin Cancer Res 14(17):5594–5601

    Article  CAS  PubMed  Google Scholar 

  • Johnatty SE, Beesley J, Gao B, Chen X, Lu Y, Law MH, Henderson MJ, Russell AJ, Hedditch EL, Emmanuel C, Fereday S, Webb PM, Goode EL, Vierkant RA, Fridley BL, Cunningham JM, Fasching PA, Beckmann MW, Ekici AB, Hogdall E, Kjaer SK, Jensen A, Hogdall C, Brown R, Paul J, Lambrechts S, Despierre E, Vergote I, Lester J, Karlan BY, Heitz F, du Bois A, Harter P, Schwaab I, Bean Y, Pejovic T, Levine DA, Goodman MT, Camey ME, Thompson PJ, Lurie G, Shildkraut J, Berchuck A, Terry KL, Cramer DW, Norris MD, Haber M, MacGregor S, deFazio A, Chenevix-Trench G (2013) ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol 131(1):8–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152–162

    Article  CAS  PubMed  Google Scholar 

  • Kartner N, Shales M, Riordan JR, Ling V (1983a) Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res 43(9):4413–4419

    CAS  PubMed  Google Scholar 

  • Kartner N, Riordan JR, Ling V (1983b) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221(4617):1285–1288

    Article  CAS  PubMed  Google Scholar 

  • Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 70(2):189–199

    Article  CAS  PubMed  Google Scholar 

  • Kim IW, Peng XH, Sauna ZE, FitzGerald PC, Xia D, Muller M, Nandigama K, Ambudkar SV (2006) The conserved tyrosine residues 401 and 1044 in ATP sites of human P-glycoprotein are critical for ATP binding and hydrolysis: evidence for a conserved subdomain, the A-loop in the ATP-binding cassette. Biochemistry 45(24):7605–7616

    Article  CAS  PubMed  Google Scholar 

  • Kimchi-Sarfaty C, Gribar JJ, Gottesman MM (2002) Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol Pharmacol 62(1):1–6

    Article  CAS  PubMed  Google Scholar 

  • Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM (2007) A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315(5811):525–528

    Article  CAS  PubMed  Google Scholar 

  • Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K (1989) P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun 162(1):224–231

    Article  CAS  PubMed  Google Scholar 

  • Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M (2013) MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson’s disease: a case-control study in Japan. Drug Metab Pharmacokinet 28(2):138–143

    Article  CAS  PubMed  Google Scholar 

  • Koo DH, Ryu MH, Ryoo BY, Beck MY, Na YS, Shin JG, Lee SS, Kim EY, Kang YK (2015) Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor. Cancer Chemother Pharmacol 75(1):173–182

    Article  CAS  PubMed  Google Scholar 

  • Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Carlson EJ, Herskowitz I, Giacomini KM, Clark AG (2003) Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics 13(8):481–494

    Article  CAS  PubMed  Google Scholar 

  • Kudla G, Murray AW, Tollervey D, Plotkin JB (2009) Coding-sequence determinants of gene expression in Escherichia coli. Science 324(5924):255–258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S (1998) HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 37(11):3594–3601

    Article  CAS  PubMed  Google Scholar 

  • Lee CG, Tang K, Cheung YB, Wong LP, Tan C, Shen H, Zhao Y, Pavanni R, Lee EJ, Wong MC, Chong SS, Tan EK (2004) MDR1, the blood-brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese. J Med Genet 41(5):e60

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee J, Wang R, Yang Y, Lu X, Zhang X, Wang L, Lou Y (2014) The effect of ABCB1 C3435T polymorphism on cyclosporine dose requirements in kidney transplant recipients: a meta-analysis. Basic Clin Pharmacol Toxicol 117(2):117–125

    Article  CAS  Google Scholar 

  • Levran O, O’Hara K, Peles E, Li D, Barral S, Ray B, Borg L, Ott J, Adelson M, Kreek MJ (2008) ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet 17(14):2219–2227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li Y, Hu X, Cai B, Chen J, Bai Y, Tang J, Liao Y, Wang L (2012) Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients. Transpl Immunol 27(1):12–18

    Article  PubMed  CAS  Google Scholar 

  • Li M, Tan J, Yang X, Su L, Xie J, Liang B, Long J, Jiang H, Wei Q, Shen T, Chen Q, Yan Y, Wu G, Gu L (2014a) The ABCB1-C3435T polymorphism likely acts as a risk factor for resistance to antiepileptic drugs. Epilepsy Res 108(6):1052–1067

    Article  CAS  PubMed  Google Scholar 

  • Li J, Jaimes KF, Aller SG (2014b) Refined structures of mouse P-glycoprotein. Protein Sci 23(1):34–46

    Article  PubMed  CAS  Google Scholar 

  • Loo TW, Clarke DM (1993a) Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. J Biol Chem 268(27):19965–19972

    CAS  PubMed  Google Scholar 

  • Loo TW, Clarke DM (1993b) Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. J Biol Chem 268(5):3143–3149

    CAS  PubMed  Google Scholar 

  • Loo TW, Bartlett MC, Clarke DM (2002) The “LSGGQ” motif in each nucleotide-binding domain of human P-glycoprotein is adjacent to the opposing walker A sequence. J Biol Chem 277(44):41303–41306

    Article  CAS  PubMed  Google Scholar 

  • Loo TW, Bartlett MC, Clarke DM (2006) Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. Biochem J 399(2):351–359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luo M, Li J, Xu X, Sun X, Sheng W (2012) ABCB1 C3435T polymorphism and risk of adverse clinical events in clopidogrel treated patients: a meta-analysis. Thromb Res 129(6):754–759

    Article  CAS  PubMed  Google Scholar 

  • Lv WP, Han RF, Shu ZR (2014) Associations between the C3435T polymorphism of the ABCB1 gene and drug resistance in epilepsy: a meta-analysis. Int J Clin Exp Med 7(11):3924–3932

    PubMed  PubMed Central  Google Scholar 

  • Macaya D, Katsanis SH, Hefferon TW, Audlin S, Mendelsohn NJ, Roggenbuck J, Cutting GR (2009) A synonymous mutation in TCOF1 causes Treacher Collins syndrome due to mis-splicing of a constitutive exon. Am J Med Genet A 149A(8):1624–1627

    Article  CAS  PubMed  Google Scholar 

  • Macphee IA, Fredericks S, Tai T, Syrris P, Carter ND, Johnston A, Goldberg L, Holt DW (2002) Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement. Transplantation 74(11):1486–1489

    Article  CAS  PubMed  Google Scholar 

  • Marcoux J, Wang SC, Politis A, Reading E, Ma J, Biggin PC, Zhou M, Tao H, Zhang Q, Chang G, Morgner N, Robinson CV (2013) Mass spectrometry reveals synergistic effects of nucleotides, lipids, and drugs binding to a multidrug resistance efflux pump. Proc Natl Acad Sci USA 110(24):9704–9709

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marsh S, Paul J, King CR, Gifford G, McLeod HL, Brown R (2007) Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. J Clin Oncol 25(29):4528–4535

    Article  CAS  PubMed  Google Scholar 

  • Mealey KL, Bentjen SA, Gay JM, Cantor GH (2001) Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11(8):727–733

    Article  CAS  PubMed  Google Scholar 

  • Megias-Vericat JE, Rojas L, Herrero MJ, Boso V, Montesinos P, Moscardo F, Poveda JL, Sanz MA, Alino SF (2015) Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies. Pharmacogenomics J 15(2):109–118

    Article  CAS  PubMed  Google Scholar 

  • Meletiadis J, Chanock S, Walsh TJ (2006) Human pharmacogenomic variations and their implications for antifungal efficacy. Clin Microbiol Rev 19(4):763–787

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W, Bates SE, Fojo T (1998) Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood 91(5):1749–1756

    CAS  PubMed  Google Scholar 

  • Mizutani T, Hattori A (2005) New horizon of MDR1 (P-glycoprotein) study. Drug Metab Rev 37(3):489–510

    Article  CAS  PubMed  Google Scholar 

  • Moran SJ, Flanagan JFt, Namy O, Stuart DI, Brierley I, Gilbert RJ (2008) The mechanics of translocation: a molecular “spring-and-ratchet” system. Structure 16(5):664–672

    Article  CAS  PubMed  Google Scholar 

  • Mylona P, Glazier JD, Greenwood SL, Sides MK, Sibley CP (1996) Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. Mol Hum Reprod 2(9):693–698

    Article  CAS  PubMed  Google Scholar 

  • Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314(5807):1930–1933

    Article  CAS  PubMed  Google Scholar 

  • Nakamura Y, Ikeda S, Furukawa T, Sumizawa T, Tani A, Akiyama S, Nagata Y (1997) Function of P-glycoprotein expressed in placenta and mole. Biochem Biophys Res Commun 235(3):849–853

    Article  CAS  PubMed  Google Scholar 

  • Nielsen KB, Sorensen S, Cartegni L, Corydon TJ, Doktor TK, Schroeder LD, Reinert LS, Elpeleg O, Krainer AR, Gregersen N, Kjems J, Andresen BS (2007) Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet 80(3):416–432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Notarangelo MF, Bontardelli F, Merlini PA (2013) Genetic and nongenetic factors influencing the response to clopidogrel. J Cardiovasc Med (Hagerstown) 14(Suppl 1):S1–7

    Article  CAS  Google Scholar 

  • Onnie CM, Fisher SA, Pattni R, Sanderson J, Forbes A, Lewis CM, Mathew CG (2006) Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm Bowel Dis 12(4):263–271

    Article  PubMed  Google Scholar 

  • Oostenbrug LE, Dijkstra G, Nolte IM, van Dullemen HM, Oosterom E, Faber KN, de Jong DJ, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL (2006) Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Scand J Gastroenterol 41(10):1174–1182

    Article  CAS  PubMed  Google Scholar 

  • Ozawa S, Soyama A, Saeki M, Fukushima-Uesaka H, Itoda M, Koyano S, Sai K, Ohno Y, Saito Y, Sawada J (2004) Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1. Drug Metab Pharmacokinet 19(2):83–95

    Article  CAS  PubMed  Google Scholar 

  • Pan JH, Han JX, Wu JM, Huang HN, Yu QZ, Sheng LJ (2009) MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer. Respiration 78(1):49–55

    Article  CAS  PubMed  Google Scholar 

  • Parmley JL, Hurst LD (2007) Exonic splicing regulatory elements skew synonymous codon usage near intron-exon boundaries in mammals. Mol Biol Evol 24(8):1600–1603

    Article  CAS  PubMed  Google Scholar 

  • Parmley JL, Chamary JV, Hurst LD (2006) Evidence for purifying selection against synonymous mutations in mammalian exonic splicing enhancers. Mol Biol Evol 23(2):301–309

    Article  CAS  PubMed  Google Scholar 

  • Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85(12):4486–4490

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pauli-Magnus C, Feiner J, Brett C, Lin E, Kroetz DL (2003) No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects. Clin Pharmacol Ther 74(5):487–498

    Article  CAS  PubMed  Google Scholar 

  • Peethambaram P, Fridley BL, Vierkant RA, Larson MC, Kalli KR, Elliott EA, Oberg AL, White KL, Rider DN, Keeney GL, Cunningham JM, Hartmann LC, Goode EL (2011) Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. Int J Mol Epidemiol Genet 2(2):185–195

    CAS  PubMed  PubMed Central  Google Scholar 

  • Petain A, Kattygnarath D, Azard J, Chatelut E, Delbaldo C, Geoerger B, Barrois M, Seronie-Vivien S, LeCesne A, Vassal G (2008) Population pharmacokinetics and pharmacogenetics of imatinib in children and adults. Clin Cancer Res 14(21):7102–7109

    Article  CAS  PubMed  Google Scholar 

  • Plotkin JB, Kudla G (2010) Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet 12(1):32–42

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Presnyak V, Alhusaini N, Chen YH, Martin S, Morris N, Kline N, Olson S, Weinberg D, Baker KE, Graveley BR, Coller J (2015) Codon optimality is a major determinant of mRNA stability. Cell 160(6):1111–1124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raymond M, Gros P (1989) Mammalian multidrug-resistance gene: correlation of exon organization with structural domains and duplication of an ancestral gene. Proc Natl Acad Sci U S A 86(17):6488–6492

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Richert ND, Aldwin L, Nitecki D, Gottesman MM, Pastan I (1988) Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells. Biochemistry 27(20):7607–7613

    Article  CAS  PubMed  Google Scholar 

  • Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V (1985) Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316(6031):817–819

    Article  CAS  PubMed  Google Scholar 

  • Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A 83(12):4538–4542

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ross S, Pare G (2013) Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran. Pharmacogenomics 14(13):1565–1572

    Article  CAS  PubMed  Google Scholar 

  • Saitoh A, Singh KK, Powell CA, Fenton T, Fletcher CV, Brundage R, Starr S, Spector SA (2005) An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children. AIDS 19(4):371–380

    Article  CAS  PubMed  Google Scholar 

  • Sauna ZE, Kim IW, Nandigama K, Kopp S, Chiba P, Ambudkar SV (2007) Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP. Biochemistry 46(48):13787–13799

    Google Scholar 

  • Schaefer M, Roots I, Gerloff T (2006) In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphisms. Pharmacogenet Genomics 16(12):855–861

    Article  CAS  PubMed  Google Scholar 

  • Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P (1995) Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96(4):1698–1705

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94(8):4028–4033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharom FJ (2011) The P-glycoprotein multidrug transporter. Essays Biochem 50(1):161–178

    Article  CAS  PubMed  Google Scholar 

  • Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM (1986) Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 232(4750):643–645

    Article  CAS  PubMed  Google Scholar 

  • Sheng X, Zhang L, Tong N, Luo D, Wang M, Xu M, Zhang Z (2012) MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies. Mol Biol Rep 39(7):7237–7249

    Article  CAS  PubMed  Google Scholar 

  • Shukla S, Sauna ZE, Ambudkar SV (2008) Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2. Leukemia 22(2):445–447

    Article  CAS  PubMed  Google Scholar 

  • Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de Lourdes Bastos M, Remiao F (2014) Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacol Ther 149:1–123

    Article  PubMed  CAS  Google Scholar 

  • Sipeky C, Csongei V, Jaromi L, Safrany E, Maasz A, Takacs I, Beres J, Fodor L, Szabo M, Melegh B (2011) Genetic variability and haplotype profile of MDR1 (ABCB1) in Roma and Hungarian population samples with a review of the literature. Drug Metab Pharmacokinet 26(2):206–215

    Article  CAS  PubMed  Google Scholar 

  • Skarke C, Jarrar M, Schmidt H, Kauert G, Langer M, Geisslinger G, Lotsch J (2003) Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers. Pharmacogenetics 13(11):651–660

    Article  CAS  PubMed  Google Scholar 

  • Smit JW, Schinkel AH, Weert B, Meijer DK (1998) Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted. Br J Pharmacol 124(2):416–424

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stein U, Walther W, Wunderlich V (1994) Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs. Eur J Cancer 30A(10):1541–1545

    Article  CAS  PubMed  Google Scholar 

  • Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, Mori S (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 48(7):1926–1929

    CAS  PubMed  Google Scholar 

  • Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, Kanamori Y, Takahashi M, Kurata Y, Kigawa J, Higuchi S, Terakawa N, Otsubo K (2001) Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 297(3):1137–1143

    CAS  PubMed  Google Scholar 

  • Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84(21):7735–7738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA (2012) Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol 124(3):575–581

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Wang B, Bi J, Li K, Di J (2012) MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies. J Cancer Res Clin Oncol 138(6):979–989

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Guo X, Yu S, Zhang J, Song J, Ji M, Cao Z, Wang J, Liu Y, Dong W (2014a) MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis. Mol Biol Rep 41(4):2679–2685

    Article  CAS  PubMed  Google Scholar 

  • Wang Q, Jin YZ, Zhou SB, Wang LJ, Lei MM, Wang Y, Miao C (2014b) ABCB1 C3435T polymorphism and the risk of ischemic heart disease: a meta-analysis. Genet Test Mol Biomarkers 18(9):636–645

    Article  CAS  PubMed  Google Scholar 

  • Wen JD, Lancaster L, Hodges C, Zeri AC, Yoshimura SH, Noller HF, Bustamante C, Tinoco I (2008) Following translation by single ribosomes one codon at a time. Nature 452(7187):598–603

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL, Schildkraut JM, Menon U, Kjaer SK, Levine DA, Gronwald J, Culver HA, Whittemore AS, Karlan BY, Lambrechts D, Wentzensen N, Kupryjanczyk J, Chang-Claude J, Bandera EV, Hogdall E, Heitz F, Kaye SB, Fasching PA, Campbell I, Goodman MT, Pejovic T, Bean Y, Lurie G, Eccles D, Hein A, Beckmann MW, Ekici AB, Paul J, Brown R, Flanagan JM, Harter P, du Bois A, Schwaab I, Hogdall CK, Lundvall L, Olson SH, Orlow I, Paddock LE, Rudolph A, Eilber U, Dansonka-Mieszkowska A, Rzepecka IK, Ziolkowska-Seta I, Brinton L, Yang H, Garcia-Closas M, Despierre E, Lambrechts S, Vergote I, Walsh C, Lester J, Sieh W, McGuire V, Rothstein JH, Ziogas A, Lubinski J, Cybulski C, Menkiszak J, Jensen A, Gayther SA, Ramus SJ, Gentry-Maharaj A, Berchuck A, Wu AH, Pike MC, Van Denberg D, Terry KL, Vitonis AF, Doherty JA, Johnatty SE, Defazio A, Song H, Tyrer J, Sellers TA, Phelan CM, Kalli KR, Cunningham JM, Fridley BL, Goode EL (2013) Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev 22(5):987–992

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wolf SJ, Bachtiar M, Wang J, Sim TS, Chong SS, Lee CG (2011) An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics. Pharmacogenomics J 11(5):315–325

    Article  CAS  PubMed  Google Scholar 

  • Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ (2004) Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein. J Pharmacol Exp Ther 310(3):1199–1207

    Article  CAS  PubMed  Google Scholar 

  • Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ (2005) MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells. AIDS 19(15):1617–1625

    Article  CAS  PubMed  Google Scholar 

  • Wu DD, Zhang JX, Li J, Dong WG (2014) Lack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: a systemic review and meta-analysis. Asian Pac J Cancer Prev 15(7):3021–3027

    Article  PubMed  Google Scholar 

  • Yamakawa Y, Hamada A, Nakashima R, Yuki M, Hirayama C, Kawaguchi T, Saito H (2011) Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Ther Drug Monit 33(2):244–250

    CAS  PubMed  Google Scholar 

  • Yao W, Yan R, Ma L, Wan H, Yu Y, Cheng X, Li Y (2014) CD243 gene polymorphism significantly associated with breast cancer susceptibility. Tumour Biol 35(8):8017–8022

    Article  CAS  PubMed  Google Scholar 

  • Zhang BB, Xuan C, Deng KF, Wu N, Lun LM (2013) Association between the MDR1 gene variant C3435T and risk of leukaemia: a meta-analysis. Eur J Cancer Care (Engl) 22(5):617–625

    Article  Google Scholar 

  • Zhao L, Li K, Li W, Yang Z (2013) Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility: a meta-analysis based on 11,339 subjects. Tumour Biol 34(3):1949–1957

    Article  CAS  PubMed  Google Scholar 

  • Zheng Q, Wu H, Yu Q, Kim DH, Lipton JH, Angelini S, Soverini S, Vivona D, Takahashi N, Cao J (2015) ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis. Pharmacogenomics J 15(2):127–134

    Article  CAS  PubMed  Google Scholar 

  • Zhou SF (2008) Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38(7–8):802–832

    Article  CAS  PubMed  Google Scholar 

  • Zu B, Li Y, Wang X, He D, Huang Z, Feng W (2014) MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis. Pharmacogenomics 15(5):667–677

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This research was funded, in part, by the Intramural Research Program of the National Institutes of Health (National Cancer Institute). We thank Dr. Di Xia for insightful discussions concerning the 3D structure of human ABCB1, and for creating the 3D model shown in Fig. 2. We also thank George Leiman for editorial assistance.

Author information

Authors and Affiliations

  1. Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2108, 20892-4254, Bethesda, MD, USA

    King Leung Fung & Michael M. Gottesman

  2. Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA

    Ryan C. Hunt & Chava Kimchi-Sarfaty

Authors
  1. King Leung Fung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan C. Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chava Kimchi-Sarfaty
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael M. Gottesman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael M. Gottesman .

Editor information

Editors and Affiliations

  1. School of Life Sciences, University of Technology, Sydney, Australia

    Anthony M. George

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Fung, K.L., Hunt, R.C., Kimchi-Sarfaty, C., Gottesman, M.M. (2016). Genetic Polymorphisms of P-glycoprotein: Echoes of Silence. In: George, A. (eds) ABC Transporters - 40 Years on. Springer, Cham. https://doi.org/10.1007/978-3-319-23476-2_6

Download citation

Publish with us

Policies and ethics

Search

Navigation